FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077456445> ?p ?o ?g. }

• W2077456445 endingPage "1889" @default.
• W2077456445 startingPage "1881" @default.
• W2077456445 abstract "Background Calcium antagonists have been shown to reduce atherogenesis and improve clinical outcomes in atherosclerotic vascular disease. No study has so far, however, addressed the effects of calcium antagonists on stent-associated neointimal formation. We therefore investigated whether a third-generation calcium antagonist, azelnidipine, attenuates in-stent neointimal formation in non-human primates. Method Male cynomolgus monkeys were fed a high cholesterol diet for 4 weeks, and were randomly assigned to three groups: a vehicle group and two other groups treated with azelnidipine at 3 and 10 mg/kg per day for an additional 24 weeks (n = 12 each). Multi-link stents were then implanted in the iliac artery. Results Azelnidipine at the high dose reduced neointimal thickness (0.25 ± 0.02 versus 0.19 ± 0.02 mm; P < 0.05). Azelnidipine also reduced local oxidative stress and monocyte chemoattractant protein 1 (MCP-1) expression. No difference was found between the three groups in the degrees of injury score, inflammation score, plaque neovascularization, or plasma lipid levels. Azelnidipine also reduced MCP-1-induced proliferation/migration of vascular smooth muscle cells in vitro. Conclusions This study demonstrated for the first time that azelnidipine attenuates in-stent neointimal formation associated with the reduced expression of MCP-1 and smooth muscle proliferation/migration in the neointima. These data in non-human primates suggest potential clinical benefits of azelnidipine as a ‘vasculoprotective calcium antagonist’ in patients undergoing vascular interventions." @default.
• W2077456445 created "2016-06-24" @default.
• W2077456445 creator A5003911575 @default.
• W2077456445 creator A5007483946 @default.
• W2077456445 creator A5014504805 @default.
• W2077456445 creator A5016612106 @default.
• W2077456445 creator A5048557340 @default.
• W2077456445 creator A5074912244 @default.
• W2077456445 creator A5074996950 @default.
• W2077456445 creator A5075158215 @default.
• W2077456445 creator A5081615897 @default.
• W2077456445 date "2006-09-01" @default.
• W2077456445 modified "2023-10-18" @default.
• W2077456445 title "A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates" @default.
• W2077456445 cites W1966214786 @default.
• W2077456445 cites W1993340561 @default.
• W2077456445 cites W2010094572 @default.
• W2077456445 cites W2019044547 @default.
• W2077456445 cites W2045075493 @default.
• W2077456445 cites W2045280877 @default.
• W2077456445 cites W2063784817 @default.
• W2077456445 cites W2064246936 @default.
• W2077456445 cites W2068900719 @default.
• W2077456445 cites W2072749612 @default.
• W2077456445 cites W2074087689 @default.
• W2077456445 cites W2074919956 @default.
• W2077456445 cites W2078870412 @default.
• W2077456445 cites W2084922957 @default.
• W2077456445 cites W2100869552 @default.
• W2077456445 cites W2112961536 @default.
• W2077456445 cites W2117140855 @default.
• W2077456445 cites W2120179549 @default.
• W2077456445 cites W2127963975 @default.
• W2077456445 cites W2137799365 @default.
• W2077456445 cites W2140177936 @default.
• W2077456445 cites W2141299792 @default.
• W2077456445 cites W2149057507 @default.
• W2077456445 cites W2150755435 @default.
• W2077456445 cites W2152070923 @default.
• W2077456445 cites W2155372623 @default.
• W2077456445 cites W2166160060 @default.
• W2077456445 cites W2172032309 @default.
• W2077456445 cites W2317397618 @default.
• W2077456445 cites W2562329777 @default.
• W2077456445 cites W3015986900 @default.
• W2077456445 doi "https://doi.org/10.1097/01.hjh.0000242414.96277.95" @default.
• W2077456445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16915039" @default.
• W2077456445 hasPublicationYear "2006" @default.
• W2077456445 type Work @default.
• W2077456445 sameAs 2077456445 @default.
• W2077456445 citedByCount "16" @default.
• W2077456445 countsByYear W20774564452012 @default.
• W2077456445 countsByYear W20774564452014 @default.
• W2077456445 countsByYear W20774564452015 @default.
• W2077456445 countsByYear W20774564452018 @default.
• W2077456445 countsByYear W20774564452021 @default.
• W2077456445 crossrefType "journal-article" @default.
• W2077456445 hasAuthorship W2077456445A5003911575 @default.
• W2077456445 hasAuthorship W2077456445A5007483946 @default.
• W2077456445 hasAuthorship W2077456445A5014504805 @default.
• W2077456445 hasAuthorship W2077456445A5016612106 @default.
• W2077456445 hasAuthorship W2077456445A5048557340 @default.
• W2077456445 hasAuthorship W2077456445A5074912244 @default.
• W2077456445 hasAuthorship W2077456445A5074996950 @default.
• W2077456445 hasAuthorship W2077456445A5075158215 @default.
• W2077456445 hasAuthorship W2077456445A5081615897 @default.
• W2077456445 hasConcept C126322002 @default.
• W2077456445 hasConcept C134018914 @default.
• W2077456445 hasConcept C164705383 @default.
• W2077456445 hasConcept C170493617 @default.
• W2077456445 hasConcept C2776885963 @default.
• W2077456445 hasConcept C2776914184 @default.
• W2077456445 hasConcept C2777339539 @default.
• W2077456445 hasConcept C2778283817 @default.
• W2077456445 hasConcept C2778583881 @default.
• W2077456445 hasConcept C2779395532 @default.
• W2077456445 hasConcept C2992686903 @default.
• W2077456445 hasConcept C519063684 @default.
• W2077456445 hasConcept C71924100 @default.
• W2077456445 hasConcept C98274493 @default.
• W2077456445 hasConceptScore W2077456445C126322002 @default.
• W2077456445 hasConceptScore W2077456445C134018914 @default.
• W2077456445 hasConceptScore W2077456445C164705383 @default.
• W2077456445 hasConceptScore W2077456445C170493617 @default.
• W2077456445 hasConceptScore W2077456445C2776885963 @default.
• W2077456445 hasConceptScore W2077456445C2776914184 @default.
• W2077456445 hasConceptScore W2077456445C2777339539 @default.
• W2077456445 hasConceptScore W2077456445C2778283817 @default.
• W2077456445 hasConceptScore W2077456445C2778583881 @default.
• W2077456445 hasConceptScore W2077456445C2779395532 @default.
• W2077456445 hasConceptScore W2077456445C2992686903 @default.
• W2077456445 hasConceptScore W2077456445C519063684 @default.
• W2077456445 hasConceptScore W2077456445C71924100 @default.
• W2077456445 hasConceptScore W2077456445C98274493 @default.
• W2077456445 hasIssue "9" @default.
• W2077456445 hasLocation W20774564451 @default.
• W2077456445 hasLocation W20774564452 @default.
• W2077456445 hasOpenAccess W2077456445 @default.

• next